Skip to content
Search AI Powered

Latest Stories

Britons warned of hospital crisis over Omicron surge but vaccine minister says patients are showing less severe symptoms

Britain on Tuesday (January 4) faced warnings of an impending hospital crisis due to staff shortages caused by a wave of Omicron infections, as the country returned to work after Christmas.

However, Britain's vaccine minister said hospitalized Covid-19 patients were showing less severe symptoms than before, adding that there was no need for further restrictions at this stage.


Prime minister Boris Johnson resisted imposing stringent lockdown measures in England ahead of New Year as Omicron fueled a spike in cases to record highs.

While hospitalizations are rising they have not tracked the trajectory of daily cases, possibly reflecting the impact of vaccines and booster shots, the likely lower severity of Omicron and the time lag in people going into hospital.

"At the moment, if you look at the people who have been hospitalized, they are going in with less severe conditions than before," minister for Vaccines and Public Health Maggie Throup told Sky News, adding that the "Plan B" Johnson brought in in December was working.

"The numbers that are in hospital beds is about half what it was a year ago - and that just shows the power of the vaccine."

Neil Ferguson, an epidemiologist at Imperial College London, said that while infections in London in under-50s may have plateaued, the incredibly steep spike in that age group had not yet had time to spread to older age groups, which are more vulnerable to Covid-19.

"We may see a different pattern in hospitalizations. Hospitalizations are still generally going up across the country, and we may see high levels for some weeks," he told BBC Radio.

"Vaccination is holding up in terms of protection against severe disease, assisted by the fact that Omicron almost certainly is substantially less severe, but it still puts pressures on the health system."

Almost impossible

Matthew Taylor, chief executive of the NHS Confederation which represents healthcare providers in England, Wales and Northern Ireland, said cases appeared to have levelled off in London.

But he told Times Radio that staff shortages and rising cases across the rest of the country were a concern.

"The unpredictability of staff absence means NHS leaders having to work around the clock just thinking about how they can deploy their resources best to deal with the most urgent and pressing needs," he added.

"Even using all their imagination and creativity, it is becoming almost impossible, which is why we see hospitals declaring critical incidents."

Anyone testing positive for the virus has to self-isolate for 10 days, or seven days if they produce a negative test.

There have been calls to ease those restrictions for health staff to ease what Johnson on Monday said was "considerable pressure" on hospitals.

Taylor said reducing the self-isolation period to five days should only be done if the data indicated it was "absolutely safe".

Pupils returning to school also faced the prospect of mass staff absences and merged classes.

Secondary school pupils have been advised to wear face masks in class as a "temporary" measure.

Transport networks also battled absences, leaving commuters facing long waits on their return to work, while other public services such as household bin collections were hampered.

Britain has seen nearly 149,000 deaths since the start of the pandemic in early 2020 and Johnson has defended his decision not to increase restrictions over Christmas in England, unlike in other parts of the UK.

A review of restrictions is expected this week.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less